Categories Nutrition & Exercise



Relevance: Medium-High


Strength of Science: Medium-High


Research Timeline: Post Approval
14 November 2024
Study : Moderate exercise delays time to breast cancer recurrence
Most relevant for: People with breast cancer who are interested in using exercise to reduce risk of recurrence
For premenopausal women with early-stage breast cancer, physical activity may increase the time before cancer returns and spreads. In this study, people with hormone receptor-negative (HR-negative) breast cancer benefited from moderate exercise—more than those with hormone receptor-positive (HR-positive) breast cancer. This study found that outcomes improved when weekly exercise time was between 90 minutes and 5 hours. (Posted 11/14/24)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium
16 April 2024
Personal Story : Living a full life with Li-Fraumeni syndrome
Most relevant for: People with Li-Fraumeni syndrome
This XRAY review is about a five-time cancer survivor who has an inherited mutation in the TP53 gene. People with inherited mutations in TP53 have Li-Fraumeni syndrome, which is linked to a very high lifetime risk for many types of cancer. Here we share his inspiring story and provide more information on Li-Fraumeni syndrome. (Posted 4/16/24)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium


Strength of Science: Medium


Research Timeline: Animal Studies
30 March 2023
Study : Weight may affect breast cancer risk in women with an inherited BRCA mutation
Most relevant for: People with an inherited mutation in BRCA1 or BRCA2 concerned about their breast cancer risk
A study that looked at normal breast cells from women with an inherited BRCA mutation found more DNA damage among women who were overweight (based on a measurement known as body mass index) than those who were not overweight. The results suggest that maintaining a lower weight may reduce breast cancer among this high-risk population. (Posted 3/30/23)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium


Strength of Science: Medium-High
24 February 2023
Study : Increasing soy in your diet may lower your cancer risk
Most relevant for: People interested in reducing cancer risk
This study looked at a link between a diet rich in soy and cancer risk. With the addition of more recent literature, this study suggests that soy lowers the risk of cancer in the general population. (Posted 2/24/23)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium


Strength of Science: Medium-High


Research Timeline: Post Approval
22 February 2023
Study : Frequent aspirin use may reduce the risk of ovarian cancer
Most relevant for: Healthy people at high-risk of ovarian cancer.
Aspirin may help lower the risk of ovarian cancer in people who have a high risk of the disease, according to a new analysis of 17 studies. While other preventive strategies have been found to more effectively lower the likelihood of developing ovarian cancer in high-risk women, taking aspirin daily or almost daily may reduce a person’s risk of developing ovarian cancer by 13 percent. The benefit was greater among people with additional risk factors for the disease. (Posted 2/22/23)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium-High


Strength of Science: High


Research Timeline: Post Approval
29 November 2022
Guideline : Guidelines on exercise, diet, and weight during cancer treatment
Most relevant for: People currently undergoing treatment for cancer
Most professional guidelines on exercise, diet and weight management have focused on the health of the general population and cancer survivors. The American Society of Clinical Oncology (ASCO) has now published evidence-based recommendations for exercise, diet and weight specifically for people who are in active treatment for cancer. (Posted 11/29/22) Este artículo está disponible en español.
READ MORE ›


Relevance: Medium-High


Strength of Science: High


Research Timeline: Post Approval
18 October 2022
Study : Resistant starch may help prevent some cancers in people with Lynch syndrome
Most relevant for: People with Lynch syndrome and people with a personal and/or family history that suggests Lynch syndrome
This study looked at whether a type of nutrient known as resistant starch could lower the risk of cancers in people with Lynch Syndrome. Researchers found that resistant starch can reduce the risk of non-colorectal cancers but not colorectal cancer. (Posted 10/17/22)
Este artículo está disponible en español.
READ MORE ›


Relevance: Medium-High


Strength of Science: High


Research Timeline: Post Approval
2 August 2022
Study : Physical activity may decrease fatigue associated with cancer treatment
Most relevant for: Cancer patients who are experiencing fatigue related to cancer or its treatment.
Many cancer survivors experience fatigue during and after they complete treatment. This study looked at the effect of home-based physical activity on fatigue in cancer survivors. It also looked at whether frequent counseling encouraged people to start and continue their exercise routines. (Posted 8/1/22). Este artículo está disponible en español.
READ MORE ›


Relevance: Medium


Strength of Science: Medium


Research Timeline: Post Approval
21 June 2022
Study : Do artificial sweeteners increase the risk of cancer?
Most relevant for: People who consume artificial sweeteners
A large study of adults in France suggests that artificial sweeteners may increase the risk of certain cancers. (posted 6/21/2022). Este artículo está disponible en español.
READ MORE ›


Relevance: Medium


Strength of Science: Medium-High


Research Timeline: Post Approval
14 April 2022
Study : Increasing melatonin use raises concerns
Most relevant for: people who take or consider taking melatonin to help with sleep.
Adult use of melatonin as a sleep aid has increased even though its benefits and risks are not well understood. This study looked at trends in melatonin use over the last 19 years. (Posted 4/14/2022)
Este artículo está disponible en español.
READ MORE ›